Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
OneSource Specialty Pharma Limited ( (IN:ONESOURCE) ) has provided an update.
OneSource Specialty Pharma Limited has received Good Manufacturing Practices (GMP) certification from ANVISA, the Brazilian Health Regulatory Agency, for its flagship Unit 2 facility. This certification, following a successful regulatory inspection, enhances the company’s operational capabilities and strengthens its position in the pharmaceutical market, potentially benefiting stakeholders by expanding its market reach in Brazil.
More about OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, operates in the pharmaceutical industry. The company specializes in providing contract development and manufacturing services, focusing on high-quality pharmaceutical production to meet global standards.
YTD Price Performance: -8.68%
Average Trading Volume: 27,864
Find detailed analytics on ONESOURCE stock on TipRanks’ Stock Analysis page.